Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Winkelmann

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Programmed death 1 immune checkpoint inhibitorsMeghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 19, 2005
Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinationsJennifer F Tseng, Christopher G Willett, Carlos Fernandez-del Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumorsDana Rathkopf, Mark A Dickson, Darren R Feldman, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2015
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumorsDavid M Hyman, Alexandra E Snyder, Richard D Carvajal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Programmed death 1 immune checkpoint inhibitorsMeghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 19, 2005
Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinationsJennifer F Tseng, Christopher G Willett, Carlos Fernandez-del Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumorsDana Rathkopf, Mark A Dickson, Darren R Feldman, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2015
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumorsDavid M Hyman, Alexandra E Snyder, Richard D Carvajal, et al.
Pageof 1